The International Contrast Ultrasound Society (ICUS)

SonoVue Approved in Mexico!

ICUS is pleased to note that the Mexican Federal Commission for Protection Against Sanitary Risk (COFEPRIS) has approved the contrast agent SonoVue in Mexico for use in echocardiography and Doppler ultrasonography. SonoVue is produced by Bracco and will be marketed in Mexico by Justesa Imagen Mexicana, S.A. de C.V.
 
ICUS applauds this action. We have long advocated for broader acceptance and appropriate use of ultrasound contrast agents, which have strong safety profiles and reduce overall health care costs without exposing patients to ionizing radiation.

ICUS Sponsors

ICUS gratefully acknowledges its 2017 sponsors:

dentons-logo2

silver-level

Toshiba Medical logo resized

samsung-logo

siemens-new-original

philips-icus-logo

mindray

ICUS Tweets

Follow Bubble Conference 2016 comment at #bubble2016
Connect live now to the 31st Annual Advances in Contrast Ultrasound "Bubble Conference" taking place in Chicago; https://t.co/67SmoW2GLn
FDA approves new liver imaging agent for adults and children; reduces exposure to harmful radiation. More at: https://t.co/3qa1vDFFhW

Contact ICUS

  • Address: 1900 K Street, N.W.
    Washington, DC 20006-1102, USA
  • Telephone: 202-408-6199

About ICUS

ICUS is the world’s only professional society exclusively devoted to contrast-enhanced ultrasound (CEUS) medical imaging technology.

Learn more...

You are here: Home ICUS News SonoVue Approved in Mexico!